Market closedNon-fractional

Profound Medical/PROF

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Profound Medical

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Ticker

PROF

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Mississauga, Canada

Employees

131

Profound Medical Metrics

BasicAdvanced
$291M
Market cap
-
P/E ratio
-$1.27
EPS
0.81
Beta
-
Dividend rate
$291M
0.81
5.41
4.645
1.093
15.779
-38.75%
-30.83%
-59.26%
27.043
6.46
6.52
-9.087
1.00%
-2.37%
1.88%
-3.45%

What the Analysts think about Profound Medical

Analyst Ratings

Majority rating from 2 analysts.
Buy

Profound Medical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-321.05% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.9M
-5.00%
Net income
-$6.1M
-31.46%
Profit margin
-321.05%
-27.85%

Profound Medical Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 5.45%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.35
-$0.26
-$0.42
-$0.26
-
Expected
-$0.35
-$0.34
-$0.32
-$0.28
-$0.29
Surprise
-1.36%
-22.71%
31.46%
-5.45%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Profound Medical stock?

Profound Medical (PROF) has a market cap of $291M as of July 06, 2024.

What is the P/E ratio for Profound Medical stock?

The price to earnings (P/E) ratio for Profound Medical (PROF) stock is 0 as of July 06, 2024.

Does Profound Medical stock pay dividends?

No, Profound Medical (PROF) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Profound Medical dividend payment date?

Profound Medical (PROF) stock does not pay dividends to its shareholders.

What is the beta indicator for Profound Medical?

Profound Medical (PROF) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Profound Medical stock

Buy or sell Profound Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing